TrivarX Completes Phase 2 MEB-001 Algorithm Sleep Study for Depressive Episodes
Medical health technology company TrivarX (ASX: TRI) has completed a Phase 2 sleep signal analysis for current major depressive episode (SAMDE) study utilising its proprietary artificial intelligence-backed algorithm MEB-001.
TrivarX Completes Phase 2 Sleep Signal Analysis for Current Major Depressive Episode Study; Shares Surge 11%
Mental health technology company TrivarX (ASX:TRI) completed phase 2 of its Sleep Signal Analysis for Current Major Depressive Episode study using its AI-backed algorithm, MEB-001, according to a
TRIVARX LTD Issues 12 Million Unquoted Options
TrivarX Ltd Aims for ASX Securities Quotation
TrivarX Recruits 362 Patients for Phase-Two MEB-001 Sleep Signal Analysis Study
TrivarX (ASX:TRI) has recruited 362 of the planned 400 patients for the second phase of a sleep signal analysis study that aims to validate the company's MEB-001 algorithm to assist in the screening a
TrivarX Receives Firm Commitments for AU$2.5 Million Share Issuance; Shares Jump 27%
TrivarX (ASX:TRI) secured firm commitments from new and existing institutional and sophisticated investors to raise AU$2.5 million, according to a Thursday filing with the Australian bourse. The menta
Trivarx Ltd Announces Major New Share Issue
TrivarX Signs Collaboration With Northern Michigan University on Sleep Research
Mental health technology company TrivarX (ASX:TRI) entered into a data transfer agreement with the Department of Psychological Sciences at Northern Michigan University to collaborate on sleep research
TrivarX Secures R&D Tax Rebate for Fiscal Year 2023; Shares Fall 4%
TrivarX (ASX:TRI) secured an AU$889,000 tax rebate for the fiscal year ended June 30, 2023, from the Australian government's research and development tax incentive scheme, according to a Thursday fili
Over Half of Patients On Track for Completion in TrivarX's SAMDE Study
More than half TrivarX's (ASX:TRI) patients enrolled for the phase 2 trial of its study on the Sleep Signal Analysis for Current Major Depressive Episode or SAMDE are on track for completion. The Aust
No Data